Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Endomind

Research Leaders

5 sponsors active, led by National Healthcare Group, Singapore

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07650344Not ApplicableRecruiting

USAGE OF ARITIFICIAL INTELLIGENCE IN AIDING WITH COLONIC SESSILE SERRATED LESIONS DETECTION AND DIAGNOSIS (AI-SSL)

NCT05006092Not ApplicableCompleted

Surveillance Modified by Artificial Intelligence in Endoscopy (SMARTIE)

Showing all 2 trials

Research Network

Common Treatments

  • Endomind1
  • Usage Of Cade System1

Active Sponsors

  • National Healthcare Group, Singapore1
  • Wuerzburg University Hospital1
  • National University Health System, Singapore1
  • Klinikum Stuttgart1
  • Changi General Hospital1

Top Investigators

Related Conditions

  • Artificial Intelligence1
  • Polyps Of Colon1
  • Sessile Serrated Lesion1
  • Surveillance Endoscopy For Colorectal Cancer1

Activity Timeline